Skip to content
The day

Thursday, November 5, 2026

Thu, Nov 55 min 53 sec

Chapters

  1. 0:09Worth readingVivos Inc, Eos Energy Enterprises, Inc., Portillo's Inc., Acumen Pharmaceuticals, Inc.
  2. 2:28Results
  3. 2:46ReportsCardinal Health Inc, Chevron Corp, Morgan Stanley, Arrow Electronics, Inc.
  4. 3:56Insider tradesEnact Holdings, Inc., Lyell Immunopharma, Inc., Hyatt Hotels Corp, Corebridge Financial, Inc.
  5. 5:14Officers
  6. 5:32What else was filed

Transcript

  1. RDGLOn October 30, 2026, Vivos Inc. completed the sale of 12,500,000 shares of common stock under its Regulation A+ offering, which resulted in gross proceeds of $1,000,000 for general working capital.
  2. EOSEAs part of a plan, the Company is consolidating its manufacturing facilities in Turtle Creek, Pennsylvania and Thorn Hill, Pennsylvania.
  3. PTLOPortillo's reported third quarter 2026 revenue of $194.1 million, up 7.0% or $12.6 million, with same-restaurant sales up 1.4%.
  4. ABOSOn November 3, 2026, the Company gave notice that it will voluntarily prepay in full, using cash on hand, all outstanding obligations under the Loan Agreement, about $23.3 million, the Payoff Amount.
  5. SOUNOn November 4, 2026, the Company implemented a restructuring plan intended to align its teams and resources with its strategic priorities to drive long-term profitability.
  6. BRCOn November 4, 2026, Brady Corporation entered into a Share Exchange Agreement with William H. Brady III, and the closing also occurred on November 4, 2026.
  7. TLSSOn November 1, 2026, the Company completed a reverse triangular merger with Patriot Glass Solutions, LLC, acquiring an indirect 80% membership interest in PGS and four patents from Badcer Ops, Inc.
  8. ISPCThe filing sets November 2, 2026 as the Closing Date for iSpecimen Inc. and Foldlab AI Ltd., a company organized under the laws of British Columbia.
  9. MEDSOn November 3, 2026, DataMeds AI gave written notice to EOS, Scilex, Datavault, HBA, THI and REBOOT terminating the Second Amended and Restated Letter of Intent, effective immediately.
  10. KRRONovo Nordisk elected on November 3, 2026 to terminate the collaboration and license agreement for convenience, effective February 1, 2027.
  11. 516 companies reported results, including Ecovyst Inc., Walker & Dunlop, Inc., First Advantage Corp, Prestige Consumer Healthcare Inc., Lincoln National Corp, ProFrac Holding Corp., Arhaus, Inc., and Celsius Holdings, Inc.
  12. CAHCardinal Health Inc filed its quarterly report, revenue $67.51B, +5.5%.
  13. CVXChevron Corp filed its quarterly report, revenue $65.24B, +35.4%.
  14. MSMorgan Stanley filed its quarterly report, revenue $20.34B, +11.6%.
  15. ARWArrow Electronics, Inc. filed its quarterly report, revenue $10.72B, +39.0%.
  16. CMICummins Inc filed its quarterly report, revenue $9.44B, +13.5%.
  17. EOGEOG Resources Inc filed its quarterly report, revenue $8.55B, +46.2%.
  18. USBUS Bancorp filed its quarterly report, revenue $7.97B, +8.7%.
  19. PHParker-Hannifin Corp filed its quarterly report, revenue $5.99B, +17.9%.
  20. 9 purchases worth $45.27M, 20 sales worth $76.60M.
  21. ACTAt Enact Holdings, Inc., Genworth Holdings, Inc., a 10% owner, sold 990,583 shares for $45.19M.
  22. LYELAt Lyell Immunopharma, Inc., ARCH Venture Fund IX, L.P., a 10% owner, bought 2,321,262 shares for $25.00M.
  23. HAt Hyatt Hotels Corp, Mark Samuel Hoplamazian, See Remarks, sold 85,000 shares for $16.00M.
  24. CRBGAt Corebridge Financial, Inc., Nippon Life Insurance Co, a 10% owner, bought 356,096 shares for $12.87M.
  25. EVTCAt Evertec, Inc., Morgan M Schuessler, President and CEO, sold 145,000 shares for $5.04M.
  26. ETRAAt Electra Therapeutics, Inc., Advisors LLC Orbimed, a Director, bought 472,571 shares for $3.61M.
  27. 49 companies reported an officer's departure or appointment, including United Parcel Service Inc, Microsoft Corp, Aspen Aerogels Inc, Commerce.com, Inc., Latigo Biotherapeutics, Inc., and 1stdibs.com, Inc.
  28. 185 6-K, 147 Form 144, 296 Schedule 13G, 14 Schedule 13D, 37 Merger communications, 19 Proxy statements, 7 S-1, 460 Prospectuses.